RedHill Biopharma Ltd. Balance Sheet

Balance Sheet Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Receivables - Doubtful 16.81M11.85M5.89M1.24M
Loans - Loss Allowance 1.25M1.34M1.55M2.62M150.84M177.43M219.50M433.86M407.74M-414.80M
Assets
Current Assets
Cash & Equivalents 14.07M16.81M11.85M5.89M21.52M53.79M16.45M29.00M29.02M29.30M29.47M19.97M5.57M4.62M
Receivables - Net 0.10M1.53M0.96M1.22M28.66M31.68M34.52M2.59M2.54M
Receivables 0.10M1.53M0.96M1.22M28.66M31.68M34.52M2.59M2.54M
Raw Materials 0.51M1.59M1.79M3.01M1.80M0.83M0.51M
Work In Process 5.20M2.38M0.23M0.31M
Finished Goods 0.65M0.26M0.29M4.73M6.60M6.83M3.33M2.83M
Inventory 0.80M1.00M1.88M6.53M7.70M11.01M4.39M3.65M
Prepaid Assets 0.09M0.20M0.49M3.07M2.37M1.56M3.29M1.88M2.24M5.52M4.66M4.39M2.80M1.10M
Current Assets 18.56M12.60M26.02M67.81M51.68M56.79M53.21M70.50M89.15M85.90M16.14M11.91M
Non-Current Assets
Property, Plant & Equipment (Net) 0.13M0.11M0.10M0.15M0.12M0.17M0.23M0.16M0.23M0.51M0.57M0.50M0.19M0.14M
Intangibles -0.04M-0.10M-0.21M-1.03M6.16M6.20M5.29M5.32M11.79M89.37M89.37M89.37M5.58M5.55M
Goodwill & Intangibles -0.04M-0.10M-0.21M-1.03M6.16M6.20M5.29M5.32M11.79M89.37M89.37M89.37M5.58M5.55M
Long-Term Deferred Tax 76.00M
Other Non-Current Assets 3.01M0.49M0.08M17.05M36.62M0.14M0.15M0.14M0.15M16.16M16.17M0.15M0.15M0.15M
Non-Current Assets 1.53M1.74M2.84M6.40M5.67M5.62M20.89M109.75M92.04M72.97M6.91M6.13M
Assets 20.19M20.10M14.34M28.86M66.83M74.21M57.34M62.41M74.10M180.24M181.19M158.87M23.05M18.04M
Liabilities
Current Liabilities
Accounts Payables 0.51M1.08M2.42M1.72M3.51M0.06M4.80M3.32M4.18M11.55M11.66M4.23M3.28M1.17M
Notes Payables 81.39M83.62M115.22M
Payables 0.51M1.08M2.42M1.72M3.51M0.06M4.80M3.32M4.18M92.94M95.28M119.45M3.28M1.17M
Accumulated Expenses 1.33M3.07M3.30M6.03M7.06M4.33M24.08M20.90M17.95M4.59M9.99M
Other Accumulated Expenses 0.21M0.30M0.36M0.42M0.71M0.77M
Short term Debt 115.22M
Current Leases 0.83M1.71M1.62M1.03M0.72M0.35M
Current Deferred Revenue 0.96M1.27M18.34M30.71M47.87M10.65M9.29M
Total Current Liabilities 1.72M5.36M11.83M10.38M10.62M73.23M81.47M197.45M19.98M22.22M
Non-Current Liabilities
Non-Current Debt 81.39M83.62M
Non-Current Deffered Revenue 0.50M0.50M0.75M0.75M0.75M0.54M
Operating Leases 2.98M3.81M2.57M6.44M0.46M0.00M
Other Non-Current Liabilities 2.69M3.27M1.87M1.53M1.06M1.06M
Total Non-Current Liabilities -1.29M-2.19M-1.87M2.12M1.24M10.45M0.45M0.84M3.48M93.14M90.84M9.82M0.99M0.50M
Total Liabilities 1.40M1.08M3.85M6.75M11.51M12.28M11.22M14.10M166.38M172.31M2.62M20.98M22.73M
Shareholder's Equity
Total Debt 81.39M83.62M115.22M
Common Equity 18.79M19.02M11.93M25.01M60.08M62.70M45.06M51.19M60.00M13.86M8.88M-48.40M2.07M-4.68M
Shareholder's Equity 25.01M60.08M62.70M45.06M51.19M60.00M13.86M8.88M-48.40M2.07M-4.68M
Liabilities and Shareholders Equity 20.19M20.10M14.34M28.86M66.83M74.21M57.34M62.41M74.10M180.24M181.19M158.87M23.05M18.04M
Retained Earnings -15.21M-23.89M-33.26M-42.22M-61.94M-89.64M-132.94M-169.09M-208.36M-280.33M-367.87M-433.86M-407.74M-414.80M
Preferred Shares 8.02M